|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6973 USD | +4.09% |
|
+1.47% | -48.35% |
| 07-15 | Rani Therapeutics Reports Positive Initial Phase 1A Data for Rt-114 for the Treatment of Obesity | CI |
| 07-15 | Rani Therapeutics Reports Positive Initial Phase 1a Data for RT-114 in Obesity | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 0.7359 | 0.8844 | 2.2 |
| Spread/Res. | -5.25% | -21.16% | -68.30% |
| Spread/Supp. | +10.23% | +10.23% | +52.18% |
| Support | 0.6326 | 0.6326 | 0.4582 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RANI Stock
- Charts Rani Therapeutics Holdings, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
